Education
About Us
Working with TipRanks
Follow Us
Spago Nanomedical AB (SE:SPAGO)
:SPAGO
SPAGO Stock Chart & Stats
kr0.10
kr0.00(0.00%)
At close: 4:00 PM EST
kr0.10
kr0.00(0.00%)
Day’s Range― - ―
52-Week Rangekr0.06 - kr0.33
Previous CloseN/A
Volume33.85K
Average Volume (3M)1.01M
Market Cap
kr66.16M
Enterprise Valuekr52.81M
Total Cash (Recent Filing)kr18.52M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta1.31
Next Earnings
Jan 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding661,572,800
10 Day Avg. Volume1,158,815
30 Day Avg. Volume1,005,829
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)1.74
Price to Sales (P/S)30.30
P/FCF Ratio-1.66
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SPAGO FAQ
What was Spago Nanomedical AB’s price range in the past 12 months?
Spago Nanomedical AB lowest stock price was kr0.06 and its highest was kr0.33 in the past 12 months.
What is Spago Nanomedical AB’s market cap?
Spago Nanomedical AB’s market cap is kr66.16M.
When is Spago Nanomedical AB’s upcoming earnings report date?
Spago Nanomedical AB’s upcoming earnings report date is Jan 29, 2026 which is in 42 days.
How were Spago Nanomedical AB’s earnings last quarter?
Spago Nanomedical AB released its earnings results on Oct 29, 2025. The company reported -kr0.013 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.013.
Is Spago Nanomedical AB overvalued?
According to Wall Street analysts Spago Nanomedical AB’s price is currently Overvalued.
Does Spago Nanomedical AB pay dividends?
Spago Nanomedical AB does not currently pay dividends.
What is Spago Nanomedical AB’s EPS estimate?
Spago Nanomedical AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Spago Nanomedical AB have?
Spago Nanomedical AB has 661,572,800 shares outstanding.
What happened to Spago Nanomedical AB’s price movement after its last earnings report?
Spago Nanomedical AB reported an EPS of -kr0.013 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -20.468%.
Which hedge fund is a major shareholder of Spago Nanomedical AB?
Currently, no hedge funds are holding shares in SE:SPAGO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Spago Nanomedical AB
Spago Nanomedical AB (SPAGO) is a Swedish biotechnology company focused on developing nanomedical products for the diagnosis and treatment of cancer. The company operates primarily in the healthcare and biotechnology sectors, with its core products centered around proprietary nanomaterial technology designed to enhance the precision and efficacy of cancer therapies and imaging.
Technical Analysis
Biosergen AB
―
Nanologica AB
―
Lipigon Pharmaceuticals AB
―
Modus Therapeutics Holding AB
―
NextCell Pharma AB
―